Jasper Therapeutics, Inc. (JSPR)

Last Year

20-May-23 -- 19-May-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

3

(1)

12

0

3

+1

0

+2

0

+3

Two Year Chart

20-May-22 -- 19-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
13-Oct-23 6:56 PM View:	13-Oct-23 Sale (Planned) ($6.78K)	Lis William Director		Jasper Therapeutics, Inc. - JSPR	(13%) 61.49K to 53.52K	0	0	--	--	Show Txns Hide Txns

09-Feb-24 8:40 PM View:	08-Feb-24 Purchase $4.53M	Velan Capital Investment Ma... 10% Owner		Jasper Therapeutics, Inc. - JSPR	32% 1.08M to 1.43M	0	0	--	--	Show Txns Hide Txns

12-Mar-24 9:33 PM View:	12-Mar-24 Planned Option Sale ($23.79K)	Mahal Jeetinder Singh Chief Operating Officer		Jasper Therapeutics, Inc. - JSPR	(91%) 287.22K to 25.01K	0	0	--	--	Show Txns Hide Txns

30-Nov-23 4:05 PM View:	28-Nov-23 Purchase $6.49K	Wiggans Thomas G Director		Jasper Therapeutics, Inc. - JSPR	100% 0 to 50.0K	0	0	--	--	Show Txns Hide Txns

12-Feb-24 6:23 PM View:	08-Feb-24 Purchase $2.46M	Carlyle Group L.P.		Jasper Therapeutics, Inc. - JSPR	22% 876.19K to 1.07M	0	0	--	--	Show Txns Hide Txns

13-Oct-23 6:57 PM View:	12-Oct-23 Payment of Exercise ($74.40K)	Martell Ron President, CEO and Director Director		Jasper Therapeutics, Inc. - JSPR	(21%) 418.72K to 331.19K	0	0	--	--	Show Txns Hide Txns